Dendritic cells during Epstein Barr virus infection

Frontiers in Microbiology

Volumn 5, Issue JUN, 2014, Pages

  Münz, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Conventional dendritic cells; Monocyte derived dendritic cells; Natural killer cells; Plasmacytoid dendritic cells; T cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL NUCLEAR RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; BURKITT LYMPHOMA; CD8+ T LYMPHOCYTE; CELL TRANSFORMATION; DENDRITIC CELL; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; LYMPHOBLASTOID CELL LINE; NATURAL KILLER CELL; NONHUMAN; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SHORT SURVEY; T LYMPHOCYTE; VIRAL TROPISM; VIRUS CARCINOGENESIS; VIRUS TRANSMISSION;

EID: 84904871790     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00308     Document Type: Short Survey

References (51)

1. Abbott, R. J., Quinn, L. L., Leese, A. M., Scholes, H. M., Pachnio, A., and Rickinson, A. B. (2013). CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response. J. Immunol. 191, 5398-5409. doi: 10.4049/jimmunol.1301629
2. Adhikary, D., Behrends, U., Moosmann, A., Witter, K., Bornkamm, G. W., and Mautner, J. (2006). Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J. Exp. Med. 203, 995-1006. doi: 10.1084/jem.20051287
3. Ariza, M. E., Glaser, R., Kaumaya, P. T., Jones, C., and Williams, M. V. (2009). The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J. Immunol. 182, 851-859. doi: 10.4049/jimmunol.182.2.851
4. Babcock, G. J., Decker, L. L., Volk, M., and Thorley-Lawson, D. A. (1998). EBV persistence in memory B cells in vivo. Immunity 9, 395-404. doi: 10.1016/S1074-7613(00)80622-6
5. Babcock, J. G., Hochberg, D., and Thorley-Lawson, A. D. (2000). The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497-506. doi: 10.1016/S1074-7613(00)00049-2
6. Bickham, K., Goodman, K., Paludan, C., Nikiforow, S., Tsang, M. L., Steinman, R. M.,et al. (2003). Dendritic cells initiate immune control of Epstein-Barr virus transformation of B lymphocytes in vitro. J. Exp. Med. 198, 1653-1663. doi: 10.1084/jem.20030646
7. Bonaccorsi, I., Morandi, B., Antsiferova, O., Costa, G., Oliveri, D., Conte, R.,et al. (2014). Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. J. Immunol. 192, 824-832. doi: 10.4049/jimmunol.1301039
8. Borza, C. M., and Hutt-Fletcher, L. M. (2002). Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8, 594-599. doi: 10.1038/nm0602-594
9. Brilot, F., Strowig, T., Roberts, S. M., Arrey, F., and Münz, C. (2007). NK cell survival mediated through the regulatory synapse with human dendritic cells requires IL-15Ralpha. J. Clin. Invest. 117, 3316-3329. doi: 10.1172/JCI31751
10. Casanova, J. L., Abel, L., and Quintana-Murci, L. (2011). Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447-491. doi: 10.1146/annurev-immunol-030409-101335
11. Cesarman, E. (2014). Gammaherpesviruses and lymphoproliferative disorders. Annu. Rev. Pathol. 9, 349-372. doi: 10.1146/annurev-pathol-012513-104656
12. Chijioke, O., Muller, A., Feederle, R., Barros, M. H., Krieg, C., Emmel, V.,et al. (2013). Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep. 5, 1489-1498. doi: 10.1016/j.celrep.2013.11.041
13. Connolly, S. A., Jackson, J. O., Jardetzky, T. S., and Longnecker, R. (2011). Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9, 369-381. doi: 10.1038/nrmicro2548
14. Epstein, M. A., Achong, B. G., and Barr, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702-703. doi: 10.1016/S0140-6736(64)91524-7
15. Ferlazzo, G., Thomas, D., Pack, M., Paludan, C., Schmid, D., Strowig, T.,et al. (2004). Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. U.S.A. 101, 16606-16611. doi: 10.1073/pnas.0407522101
16. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., and Münz, C. (2002). Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351. doi: 10.1084/jem.20011149
17. Fiola, S., Gosselin, D., Takada, K., and Gosselin, J. (2010). TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185, 3620-3631. doi: 10.4049/jimmunol.0903736
18. Gaudreault, E., Fiola, S., Olivier, M., and Gosselin, J. (2007). Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 81, 8016-8024. doi: 10.1128/JVI.00403-07
19. Gottschalk, S., Rooney, C. M., and Heslop, H. E. (2005). Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 56, 29-44. doi: 10.1146/annurev.med.56.082103.104727
20. Guerreiro-Cacais, A. O., Li, L., Donati, D., Bejarano, M. T., Morgan, A., Masucci, M. G.,et al. (2004). Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J. Gen. Virol. 85, 2767-2778. doi: 10.1099/vir.0.80140-0
21. Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F.,et al. (2008). Targeting the nuclear antigen 1 of Epstein Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112, 1231-1239. doi: 10.1182/blood-2008-03-148072
22. Hislop, A. D., Taylor, G. S., Sauce, D., and Rickinson, A. B. (2007). Cellular responses to viral infection in humans: lessons from epstein-barr virus. Annu. Rev. Immunol. 25, 587-617. doi: 10.1146/annurev.immunol.25.022106.141553
23. Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J. S.,et al. (2003). Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N. Engl. J. Med. 349, 1324-1332. doi: 10.1056/NEJMoa023141
24. Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T.,et al. (2009). Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206, 2091-2099. doi: 10.1084/jem.20081761
25. Iwasaki, A., and Medzhitov, R. (2004). Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995. doi: 10.1038/ni1112
26. Kutok, J. L., and Wang, F. (2006). Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1, 375-404. doi: 10.1146/annurev.pathol.1.110304.100209
27. Laichalk, L. L., and Thorley-Lawson, D. A. (2005). Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79, 1296-1307. doi: 10.1128/JVI.79.2.1296-1307.2005
28. Leung, C., Chijioke, O., Gujer, C., Chatterjee, B., Antsiferova, O., Landtwing, V.,et al. (2013a). Infectious diseases in humanized mice. Eur. J. Immunol. 43, 2246-2254. doi: 10.1002/eji.201343815
29. Leung, C. S., Maurer, M. A., Meixlsperger, S., Lippmann, A., Cheong, C., Zuo, J.,et al. (2013b). Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. Blood 121, 1584-1594. doi: 10.1182/blood-2012-08-450775
30. Li, L., Liu, D., Hutt-Fletcher, L., Morgan, A., Masucci, M. G., and Levitsky, V. (2002). Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99, 3725-3734. doi: 10.1182/blood.V99.10.3725
31. Lim, W. H., Kireta, S., Russ, G. R., and Coates, P. T. (2006). Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 109, 1043-1050. doi: 10.1182/blood-2005-12-024802
32. Lotz, M., Tsoukas, C. D., Fong, S., Carson, D. A., and Vaughan, J. H. (1985). Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur. J. Immunol. 15, 520-525. doi: 10.1002/eji.1830150518
33. Lucas, M., Schachterle, W., Oberle, K., Aichele, P., and Diefenbach, A. (2007). Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517. doi: 10.1016/j.immuni.2007.03.006
34. Lünemann, A., Vanoaica, L. D., Azzi, T., Nadal, D., and Münz, C. (2013). A distinct subpopulation of human natural killer cells restricts B cell transformation by the Epstein-Barr virus. J. Immunol. 191, 4989-4995. doi: 10.4049/jimmunol.1301046
35. Meixlsperger, S., Leung, C. S., Ramer, P. C., Pack, M., Vanoaica, L. D., Breton, G.,et al. (2013). CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 121, 5034-5044. doi: 10.1182/blood-2012-12-473413
36. Münz, C., Bickham, K. L., Subklewe, M., Tsang, M. L., Chahroudi, A., Kurilla, M. G.,et al. (2000). Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191, 1649-1660. doi: 10.1084/jem.191.10.1649
37. Pappworth, I. Y., Wang, E. C., and Rowe, M. (2007). The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing. J. Virol. 81, 474-482. doi: 10.1128/JVI.01777-06
38. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L., and Sisirak, V. (2011). Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183. doi: 10.1146/annurev-immunol-031210-101345
39. Rickinson, A. B., Long, H. M., Palendira, U., Münz C., and Hislop, A. (2014). Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 35, 159-169. doi: 10.1016/j.it.2014.01.003
40. Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., and Takada, K. (2006). EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25, 4207-4214. doi: 10.1038/sj.emboj.7601314
41. Savoldo, B., Cubbage, M. L., Durett, A. G., Goss, J., Huls, M. H., Liu, Z.,et al. (2002). Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J. Immunol. 168, 909-918. doi: 10.4049/jimmunol.168.2.909
42. Severa, M., Giacomini, E., Gafa, V., Anastasiadou, E., Rizzo, F., Corazzari, M.,et al. (2013). EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape. Eur. J. Immunol. 43, 147-158. doi: 10.1002/eji.201242552
43. Strowig, T., Brilot, F., Arrey, F., Bougras, G., Thomas, D., Muller, W. A.,et al. (2008). Tonsilar natural killer cells restrict B cell transformation by the Epstein Barr virus via IFN-?. PLoS Pathog. 4:e40027. doi: 10.1371/journal.ppat.0040027
44. Strowig, T., Chijioke, O., Carrega, P., Arrey, F., Meixlsperger, S., Ramer, P. C.,et al. (2010). Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116, 4158-4167. doi: 10.1182/blood-2010-02-270678
45. Strowig, T., Gurer, C., Ploss, A., Liu, Y. F., Arrey, F., Sashihara, J.,et al. (2009). Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 206, 1423-1434. doi: 10.1084/jem.20081720
46. Subklewe, M., Paludan, C., Tsang, M. L., Mahnke, K., Steinman, R. M., and Münz, C. (2001). Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8+ killer T cells. J. Exp. Med. 193, 405-411. doi: 10.1084/jem.193.3.405
47. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33, 27-32. doi: 10.1002/ijc.2910330106
48. Thacker, E. L., Mirzaei, F., and Ascherio, A. (2006). Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol. 59, 499-503. doi: 10.1002/ana.20820
49. Tugizov, S. M., Berline, J. W., and Palefsky, J. M. (2003). Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat. Med. 9, 307-314. doi: 10.1038/nm830
50. Woellmer, A., Arteaga-Salas, J. M., and Hammerschmidt, W. (2012). BZLF1 Governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression. PLoS Pathog. 8:e1002902. doi: 10.1371/journal.ppat.1002902
51. Younesi, V., Shirazi, F. G., Memarian, A., Amanzadeh, A., Jeddi-Tehrani, M., and Shokri, F. (2014). Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay. Cytotechnology 66, 95-105. doi: 10.1007/s10616-013-9542-x